Vitamins for epilepsy

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Ranganathan, Lakshmi Narasimhan ^a   Ramaratnam, Sridharan ^b  

^a Kilpauk Medical College   (India)

^b APOLLO HOSPITALS   (India)

Author keywords

Anticonvulsants adverse effects; antagonists inhibitors ; Epilepsy *prevention control ; Folic acid therapeutic use ; Randomized controlled trials as topic; Thiamine therapeutic use ; Vitamin A therapeutic use ; Vitamin D therapeutic use ; Vitamins *therapeutic use

Indexed keywords

ALPHA TOCOPHEROL; ANTICONVULSIVE AGENT; FOLIC ACID; PHENOBARBITAL; PHENYTOIN; THIAMINE; VITAMIN; VITAMIN D;

ALKALINE PHOSPHATASE BLOOD LEVEL; ALLERGIC RASH; ATAXIA; BEHAVIOR CHANGE; BIRTH DEFECT; BONE MARROW TOXICITY; BONE MINERAL; CALCIUM BLOOD LEVEL; COCHRANE LIBRARY; COGNITION; DIPLOPIA; DIZZINESS; DRUG MECHANISM; ENDOCRINE DISEASE; EPILEPSY; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; HUMAN; LIVER TOXICITY; MOOD; NAUSEA; NEPHROTOXICITY; NEUROLOGIC DISEASE; NEUROPATHY; NEUROPSYCHOLOGY; OSTEOMALACIA; OSTEOPOROSIS; QUALITY OF LIFE; REVIEW; SEIZURE; SIDE EFFECT; SKIN ALLERGY; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SYSTEMATIC REVIEW; TOXIC EPIDERMAL NECROLYSIS; VITAMIN SUPPLEMENTATION; VOMITING;

EID: 77950107771     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004304.pub2     Document Type: Review

References (43)

1. Backman 1989 {published data only} * Backman N, Holm AK, Blomquist HK, Hiejbel J, Safstrom G. Folate treatment of diphenylhydantoin-induced gingival hyperplasia. Scandinavian Journal of Dental Research 1989;97(3): 222-32.
2. Botez 1993 {published data only} * Botez MI, Botez T, Ross-Chouinard A, Lalonde R. Thiamine and folate treatment of chronic epileptic patients: a controlled study with the Wechsler IQ scale. Epilepsy Research 1993;16:157-63.
3. Bowe 1971 {published data only} * Bowe JC, Cornish EJ, Dawson M. Evaluation of folic acid supplements in children taking phenytoin. Developmental Medicine and Child Neurology 1971;13:343-54.
4. Brown 1991 {published data only} * Brown RS, Di Stanislao PT, Beaver WT, Bottomley WK. The administration of folic acid to institutionalized epileptic adults with phenytoin-induced gingival hyperplasia. Oral Surgery, Oral Medicine and Oral Pathology 1991;71:565-8.
5. Christiansen 1973a {published data only} * Christiansen C, Rodbro P, Lund M. Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. British Medical Journal 1973;4(5894):695-701.
6. Christiansen 1975 {published data only} * Christiansen C, Rodbro P, Nielsen CT. Iatrogenic osteomalacia in epileptic children. Acta Paediatrica 1975;64(2):219-24.
7. Drew 1987 {published data only} * Drew HJ, Vogel RI, Molofsky W, Baker H, Frank O. Effect of folate on phenytoin hyperplasia. Journal of Clinical Periodontology 1987;14(6):350-6.
8. Gibberd 1981 {published data only} * Gibberd FB, Nicholls A, Wright MG. The influence of folic acid on the frequency of epileptic attacks. European Journal of Clinical Pharmacology 1981;19(1):57- 60.
9. Grant 1970 {published data only} * Grant RH, Stores OP. Folic acid in folate-deficient patients with epilepsy. British Medical Journal 1970;4(736):644-8.
10. Horwitz 1968 {published data only} * Horwitz SJ, Klipstein FA, Lovelace RE. Relation of abnormal folate metabolism to neuropathy developing during anticonvulsant drug therapy. Lancet 1968;1(7542):563-5.
11. Jensen 1970 {published data only} * Jensen ON, Olesen OV. Subnormal serum folate due to anticonvulsive therapy. A double blind study of the effect of folic acid treatments in patients with drug-induced subnormal serum folates. Archives of Neurology 1970;22(2):181-2.
12. Mattson 1973 {published data only} * Mattson RH, Gallagher BB, Reynolds EH, Glass D. Folate therapy in epilepsy. A controlled study. Archives of Neurology 1973; 29(2):78-81.
13. Ogunmekan 1989 {published data only} * Ogunmekan AO, Hwang PA. A Randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopheryl acetate (vitamin E), as add-on therapy, for epilepsy in children. Epilepsia 1989;30(1):84-9.
14. Poppell 1991 {published data only} * Poppell TD, Keeling SD, Collins JF, Hassell TM. Effect of folic acid on recurrence of phenytoin-induced gingival overgrowth following gingivectomy. Journal of Clinical Periodontology 1991;18 (2):134-9.
15. Ralston 1970 {published data only} * Ralston AJ, Snaith RP, Hinley JB. Effect of folic acid on fitfrequency and behaviour in epileptics on anticonvulsants. Lancet 1970;1(7652):867-8.
16. Christiansen 1973b {published data only} * Christiansen C, Rodbro P, Lund M. Effect of vitamin D on bone mineral mass in normal subjects and in epileptic patients on anticonvulsants: a controlled therapeutic trial. British Medical Journal 1973;2(5860):208-9.
17. Christiansen 1974 {published data only} * Claus Christiansen, Paul Rodbro, Ole Sjo. "Anticonvulsant Action" of vitamin D in epileptic patients? A controlled pilot study. British Medical Journal 1974;2(913):258-9.
18. Jekovec-Vrhovse 2000 {published data only} * Jekovec-Vrhovse M, Kocijancic A, Prezelj J. Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full time care. Developmental Medicine and Child Neurology 2000;42:403-5.
19. Jiao 1997 {published data only} * Jiao FY, Gao DY, Takuma Y, Wu S, Liu ZY, Zhang XK, et al.Randomized, controlled trial of high dose intravenous pyridoxine in the treatment of recurrent seizures in children. Pediatric Neurology 1997;17(1):54-7.
20. McKiernan 1981 {published data only} * McKiernan J, Mellor DH, Court S. A controlled trial of pyridoxine supplementation in children with febrile convulsions. Clinical Pediatrics 1981;20(3):208-11.
21. Moore 1972 {published data only} * Moore JR, Ball EW. Folic acid replacement in folate-deficient children on anticonvulsants. Archives of Disease in Childhood 1972; 47(252):309-11.
22. Norris 1971 {published data only} * Norris JW, Pratt RF. A controlled study of folic acid in epilepsy. Neurology 1971;21(6):659-64.
23. Raju 1994 {published data only} * Raju GB, Behari M, Prasad K, Ahuja GK. Randomized, doubleblind, placebo-controlled, clinical trial of D-alpha-tocopherol (vitamin E) as add-on therapy in uncontrolled epilepsy. Epilepsia 1994;35(2):368-72.
24. Rodbro 1975 {published data only} * Roodbro P, Christiansen C, Lund M. Subjective symptoms in epileptic patients on anticonvulsant drugs. Acta Neurologica Scandinavica 1975;52(2):87- 93.
25. Tjellesen 1985 {published data only} * Tjellesen L, Gotfredsen, Christiansen C. Different actions of vitamin D2 and D3 on bone metabolism in patients treated with phenobarbitone/phenytoin. Calcified Tissue International 1985;37 (3):218-22.
26. Adab 2004 Adab N, Tudur Smith C, Vinten J, Williamson P, Winterbottom J. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database of Systematic Reviews 2004, Issue 4.[Art. No.: CD004848. DOI: 10.1002/14651858.CD004848]
27. Bazil 2003 Bazil CW, Pedley TA. Clinical pharmacology of antiepileptic drugs. Clinical Neuropharmacology 2003;26(1):38-52.
28. Christiansen 1974 Christiansen C, Rodbro P, Sjo O. "Anticonvulsant action" of vitamin D in epileptic patients? A controlled pilot study. British Medical Journal 1974;2(913):258-9.
29. Commission 1989 Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
30. Dorland 1994 Dorland's Illustrated Medical Dictionary. 28th Edition. Philadelphia: Saunders, 1994.
31. El Sayed 1998 El-Sayed YY. Obstetric and gynaecologic care of women with epilepsy. Epilepsia 1998;39(suppl 8):S17-25.
32. Gupta 2001 Gupta VK, Mishra D, Mathur I, Singh KK. Pyridoxine-dependent seizures: a case report and critical review of the literature. Journal of Paediatric Child Health 2001;37(6):592-6.
33. Hauser 1993 Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizure in Rochester, Minnesota:1935-1984. Epilepsia 1993;34(3):453-68.
34. Holland 2001 Holland KD. Efficacy, pharmacology and adverse effects of antiepileptic drugs. Neurologic Clinics 2001;19(2):313- 45.
35. Horwitz 1968 Horwitz SJ, Klipstein FA, Lovelace RE. Relation of abnormal folate metabolism to neuropathy developing during anticonvulsant drug therapy. Lancet 1968;1(7542):563-5.
36. Jiao 1997 Jiao FY, Gao DY, Takuma Y, Wu S, Liu ZY, Zhang XK, et al.Randomized, controlled trial of high-dose intravenous pyridoxine in the treatment of recurrent seizures in children. Pediatric Neurology 1997;17(1):54-7.
37. Lindhout 1986 Lindhout D, Schmidt D. In-utero exposure to valproate and neural tube defects. The Lancet 1986;1(8494):1392-3.
38. Lumley 2001 Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database of Systematic Reviews 2001, Issue 1.[Art. No.: CD001056. DOI: 10.1002/14651858.CD001056]
39. Marriott 1997 Marriott BM. Vitamin D Supplementation: a word of caution. Annals of Internal Medicine 1997;127(3):231-3.
40. Raju 1994 Raju GB, Behari M, Prasad K, Ahuja GK. Randomized, doubleblind, placebo-controlled, clinical trial of D-alpha-tocopherol (vitamin E) as add-on therapy in uncontrolled epilepsy. Epilepsia 1994;35(2):368-72.
41. Rantala 1997 Rantala H, Tarkka R, Uhari M. A meta-analytic review of the preventive treatment of recurrences of febrile seizures. Journal of Pediatrics 1997;131(6):922-5.
42. Rosa 1991 Rosa FW. Spina bifida in infants of women tested with carbamazepine during pregnancy. New England Journal of Medicine 1991;324(10):674-7.
43. Sander 1996 Sander JW, Shorvon SD. Epidemiology of the epilepsies. Journal of Neurology, Neurosurgery, and Psychiatry 1996;61(5): 433-43.